[go: up one dir, main page]

WO2000049383A1 - Combined en bloc staining and embedding process - Google Patents

Combined en bloc staining and embedding process Download PDF

Info

Publication number
WO2000049383A1
WO2000049383A1 PCT/US2000/001953 US0001953W WO0049383A1 WO 2000049383 A1 WO2000049383 A1 WO 2000049383A1 US 0001953 W US0001953 W US 0001953W WO 0049383 A1 WO0049383 A1 WO 0049383A1
Authority
WO
WIPO (PCT)
Prior art keywords
embedding
sample
tissue
dye
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/001953
Other languages
French (fr)
Inventor
Russell L. Kerschmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resolution Sciences Corp
Original Assignee
Resolution Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resolution Sciences Corp filed Critical Resolution Sciences Corp
Priority to EP00905746A priority Critical patent/EP1155300A4/en
Priority to AU27381/00A priority patent/AU2738100A/en
Priority to HK02106739.1A priority patent/HK1045189A1/en
Priority to JP2000600075A priority patent/JP2002537554A/en
Publication of WO2000049383A1 publication Critical patent/WO2000049383A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/36Embedding or analogous mounting of samples

Definitions

  • the invention relates to a method of processing a tissue sample for imaging.
  • the preparation of organic tissue samples and other material for transmission microscopy, both visible light and electron microscopy is normally carried out by subjecting the samples to a series of chemical treatments culminating in the production of a solid block in which the sample is embedded.
  • the tissue is first chemically fixed with formalin, gluteraldehyde, or other materials which serve to preserve the sample from autolysis (self- degradation), and to render the sample rigid as well as to increase its permeability, thereby enhancing the infiltration of subsequent solutions.
  • the infiltration steps that follow fixation are designed to remove all of the water from the sample through progressive replacement with increasing concentrations of organic solvents such as alcohol and xylene.
  • the last step in the infiltration process is to infiltrate the tissue with melted paraffin. The temperature of the sample is then lowered to room temperature, whereupon the infiltrated tissue solidifies. The hardened, infiltrated tissue is then positioned in a mold and surrounded by additional paraffin to produce a tissue block.
  • tissue blocks Apart from paraffin, plastic is also widely employed for producing tissue blocks. This may be methacrylate, epoxy polymer, or related material, but in any case the tissue is subjected to a process roughly similar to that employed in paraffin processing.
  • the water in the tissue is replaced by organic solvents, which are in turn replaced by liquid polymer.
  • the mixed precursor components of the polymer are made to solidify (polymerize) by various means, including exposure to ultraviolet light, heat, or by addition of a chemical catalyst.
  • Plastic processing has been adopted for both light and electron microscopy.
  • the block containing the tissue is sectioned on a microtome. In the case of light microscopy, the sections are collected and placed on glass slides. Once secured on the slides, the sections are then stained with any number of dyes which label particular parts of the cell (e.g., nucleic acids, lipids, etc.) or, alternatively, are processed for immunohistochemistry.
  • the invention features a method for en bloc staining and embedding a sample, including the steps of (a) immersing the sample in a staining solution containing a dye that binds reversibly to a component of the sample, and (b) embedding the sample in an embedding medium, wherein the dye is no more than 50% as soluble in the embedding medium as it is in the staining solution.
  • the embedding medium is also the infiltrating substance, and may include an opacification substance.
  • the dye is no more than 20% as soluble in the embedding medium than it is in the staining solution; and more preferably, the dye is no more than 10% or even 2% as soluble in the embedding medium than it is in the staining solution.
  • the sample is a biological tissue sample, such as a sample obtained by human autopsy or from a patient from whom a biopsy has been obtained.
  • sample is used herein to refer to the tissue or other material which is to be stained and embedded.
  • the sample prior to staining, has not been prepared by microtomy.
  • the thickness of a sample is greater than 200 microns, and can be greater than one millimeter, one centimeter, or more.
  • fixation is used herein to refer to the treatment of tissue specimens with a chemical solution that preserves, hardens, and permeabilizes the sample.
  • infiltration is used herein to refer to treating the tissue with a liquid or series of liquids that penetrate throughout the tissue to the molecular level and are then transformed into a solid in order to render the sample rigid.
  • the terms “embedding” and “embedment” are used herein to refer to containing the infiltrated tissue in a mold and surrounding it with a substance (usually the same as the infiltrating substance) which is then hardened to form an encasing block.
  • the embedding substance thus serves to provide rigid support and to facilitate the cutting process.
  • sectioning is used herein to refer to cutting from the block thin slices that may then be mounted on glass slides or other support.
  • staining is used herein to refer to treating tissue with a colored or fluorescent substance that associates with the tissue on the molecular level.
  • polar and hydrophilic are used synonymously herein to refer to chemical substances which are strongly water-soluble, while the terms “non-polar” and “hydrophobic” refer to chemical materials which are poorly water-soluble, but instead are readily soluble in organic solvents, and in fats or lipids.
  • opacification agent is used herein to mean a substance added to the embedding and infiltration medium to produce a very high absorbance which suppresses images of tissue originating from more than a few microns deep in the block.
  • An exemplary opacification agent is Fat Brown RR (Solvent Brown 1 ; Sigma Chemicals, St. Louis, MO).
  • non-polar infiltration and embedding materials such as epoxy or paraffin, in which polar dyes display little solubility, together with staining the tissue with polar dyes, allows the polar dyes to be partitioned into the tissue to stain hydrophilic components such as proteins and inhibits the dyes from entering the surrounding medium, promoting a high contrast image.
  • non-polar, fat-soluble (i.e., hydrophobic) dyes can be employed to stain lipid-rich structures in tissue, for example cell membranes.
  • polar embedding materials such as glycol methacrylate (Polysciences, Inc. Warrington, PA) are employed to prevent diffusion of the non-polar dyes from the tissues into the embedding medium, thereby enhancing contrast in the tissue image.
  • a primary reason for the invention's importance is that the infiltration and embedding medium is not removed following en bloc staining and prior to imaging in some types of microscopy, including block face microscopy. Therefore it, is important for the creation of high contrast images using these techniques that image signals originating from the embedding material itself be eliminated; i.e., high contrast between the sample and the embedding medium is essential.
  • polar embedding media such as glycol methacrylate and Carbowax (solid polyethylene glycol; Union Carbide Corp., Danbury CT)
  • solubility of any dye in a given medium can be experimentally determined for any given medium.
  • neutral red (3-amino-7-dimethylamino-2-methylphenazine hydrochloride), which stains the golgi apparatus, exhibits 4.0% (0.4g/L) solubility in water, 1.8% in absolute ethanol, 3.0% in ethylene glycol, and practically no solubility in xylene (Merck index, supra).
  • Another dye, Eosin Y has the following solubility: 44.0% in water; 2.0% in ethanol; 25.0%) in Cellosolve; 27.5% in ethylene glycol; and less than 0.1 % in xylene (Electron Microscopy Sciences, Fort Washington, PA, 1999 catalog).
  • the most important element of the method of the invention is that the dye solubility in the embedding solution is less than the dye solubility in the staining solution.
  • this percentage is less than 50%, more preferably less than 20%, and most preferably less than 10%, or even 2%.
  • Table 1 contains a list of dyes compatible with polar staining solutions, and corresponding non-polar embedding media suitable for the invention described herein. Table 1 also contains a list of polar embedding media compatible with Nile Red staining of lipids. These lists are for illustrative purposes, and are not limiting in any way. It is understood that other dyes, such as those listed in Conn, H.J. "Biological Stain” 9th ed., The Williams and Wilkens Co., Baltimore 1977, may be compatible with one or more embedding medium listed below. Similarly, other embedding media may be compatible with the dyes, provided, for example, in Table 1 or in Conn (supra).
  • a tissue preparation where proteins in the sample are to be en bloc stained contains the following components, in which the dye is highly water soluble and the embedding medium is hydrophobic:
  • Dye 2% aqueous solution of eosin Y fluorescent stain (Sigma Chemicals, St. Louis, MO).
  • Embedding/infiltration medium paraffin-based embedding medium
  • Opacification agent saturated Fat Brown RR (Solvent Brown 1 ; Sigma Chemicals, St. Louis, MO)
  • Opacified medium is prepared by dissolving an excess of opacification agent in molten paraffin under moderate stirring. The mixture is allowed to settle for one hour under continued heating, and then decanted. Tissue samples are stained by immersion in the eosin Y solution, and subsequently processed through graded alcohols and xylene, then infiltrated with and embedded in the opacified medium. Tissue blocks are imaged on block face microscope.
  • Example 2
  • Embedding/infiltration medium Epon epoxy medium (Polysciences, Inc., Warrington, PA).
  • Epon is prepared according to manufacturer's instructions. Tissue samples are stained by immersion in the propidium iodide solution, and subsequently processed through graded alcohols and xylene, then infiltrated with and embedded in the epoxy medium. Tissue blocks are imaged on a surface imaging microscope.
  • a tissue preparation method where neutral lipids in the sample are to be stained contains the following components, in which the dye has low water solubility and the embedding medium is highly water soluble:
  • Dye 1% solution of Nile Red stain (Molecular Probes, Eugene, OR), dissolved in 2-methoxyethanol.
  • Embedding/infiltration medium Full strength glycol methacrylate catalyzed infiltration resin (JB-4, Polysciences, Inc., Warrington, PA) Tissue samples are placed in the stain solution in individual lOmL vials and mixed by rotation for 24 hours. The infiltrated and stained samples are then transferred to 2mL embedding capsules with an excess of formulation, mixed by rotation for 24 hours, centrifuged at 5,000 m for 10 minutes to facilitate settling of the sample, and allowed to polymerize at room temperature (approximately 1 hour). The block is imaged on a surface imaging microscope.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Microscoopes, Condenser (AREA)

Abstract

The invention features a method for en bloc staining and embedding a sample, including the steps of (a) immersing the sample in a staining solution containing a dye that binds reversibly to a component of the sample, and (b) embedding the sample in an embedding medium, wherein the dye is no more than 50 % as soluble in the embedding medium as it is in the staining solution.

Description

COMBINED EN BLOC STAINING AND EMBEDDING PROCESS BACKGROUND OF THE INVENTION
The invention relates to a method of processing a tissue sample for imaging. In present day practice, the preparation of organic tissue samples and other material for transmission microscopy, both visible light and electron microscopy, is normally carried out by subjecting the samples to a series of chemical treatments culminating in the production of a solid block in which the sample is embedded.
In this process the tissue is first chemically fixed with formalin, gluteraldehyde, or other materials which serve to preserve the sample from autolysis (self- degradation), and to render the sample rigid as well as to increase its permeability, thereby enhancing the infiltration of subsequent solutions. The infiltration steps that follow fixation are designed to remove all of the water from the sample through progressive replacement with increasing concentrations of organic solvents such as alcohol and xylene. In the case of conventional light microscopy, the last step in the infiltration process is to infiltrate the tissue with melted paraffin. The temperature of the sample is then lowered to room temperature, whereupon the infiltrated tissue solidifies. The hardened, infiltrated tissue is then positioned in a mold and surrounded by additional paraffin to produce a tissue block.
Apart from paraffin, plastic is also widely employed for producing tissue blocks. This may be methacrylate, epoxy polymer, or related material, but in any case the tissue is subjected to a process roughly similar to that employed in paraffin processing. The water in the tissue is replaced by organic solvents, which are in turn replaced by liquid polymer. The mixed precursor components of the polymer are made to solidify (polymerize) by various means, including exposure to ultraviolet light, heat, or by addition of a chemical catalyst. Plastic processing has been adopted for both light and electron microscopy. For each of these methods, the block containing the tissue is sectioned on a microtome. In the case of light microscopy, the sections are collected and placed on glass slides. Once secured on the slides, the sections are then stained with any number of dyes which label particular parts of the cell (e.g., nucleic acids, lipids, etc.) or, alternatively, are processed for immunohistochemistry.
Alternatively, methods have been introduced for en bloc staining, wherein the entire sample is stained by immersion, prior to being subjected to infiltration and embedment. Sections are then cut from the block for transmission microscopy, or the cut face of the block itself is imaged in a process called block face microscopy. In the latter case, including that implemented in the Surface Imaging Microscope (U.S. patent number 4,960,330, "Image Recording Apparatus"), a sample that has been stained en bloc with fluorescent dyes is subsequently infiltrated by and embedded in a medium, commonly a plastic polymer, that is heavily opacified or otherwise treated to allow for the suppression of images of tissue originating from more than a few microns deep in the block. This results in the production of a thin, "virtual section" closely resembling a conventional glass-slide mounted tissue section.
SUMMARY ΩE THE INVENTION
The invention features a method for en bloc staining and embedding a sample, including the steps of (a) immersing the sample in a staining solution containing a dye that binds reversibly to a component of the sample, and (b) embedding the sample in an embedding medium, wherein the dye is no more than 50% as soluble in the embedding medium as it is in the staining solution.
Preferably, the embedding medium is also the infiltrating substance, and may include an opacification substance. Preferably, the dye is no more than 20% as soluble in the embedding medium than it is in the staining solution; and more preferably, the dye is no more than 10% or even 2% as soluble in the embedding medium than it is in the staining solution. In other preferred embodiments, the sample is a biological tissue sample, such as a sample obtained by human autopsy or from a patient from whom a biopsy has been obtained.
The term "sample" is used herein to refer to the tissue or other material which is to be stained and embedded. The sample, prior to staining, has not been prepared by microtomy. The thickness of a sample is greater than 200 microns, and can be greater than one millimeter, one centimeter, or more.
The term "fixation" is used herein to refer to the treatment of tissue specimens with a chemical solution that preserves, hardens, and permeabilizes the sample. The term "infiltration" is used herein to refer to treating the tissue with a liquid or series of liquids that penetrate throughout the tissue to the molecular level and are then transformed into a solid in order to render the sample rigid.
The terms "embedding" and "embedment" are used herein to refer to containing the infiltrated tissue in a mold and surrounding it with a substance (usually the same as the infiltrating substance) which is then hardened to form an encasing block. The embedding substance thus serves to provide rigid support and to facilitate the cutting process.
The term "sectioning" is used herein to refer to cutting from the block thin slices that may then be mounted on glass slides or other support. The term "staining" is used herein to refer to treating tissue with a colored or fluorescent substance that associates with the tissue on the molecular level.
The terms "polar" and "hydrophilic" are used synonymously herein to refer to chemical substances which are strongly water-soluble, while the terms "non-polar" and "hydrophobic" refer to chemical materials which are poorly water-soluble, but instead are readily soluble in organic solvents, and in fats or lipids.
The term "opacification agent" is used herein to mean a substance added to the embedding and infiltration medium to produce a very high absorbance which suppresses images of tissue originating from more than a few microns deep in the block. An exemplary opacification agent is Fat Brown RR (Solvent Brown 1 ; Sigma Chemicals, St. Louis, MO).
The use of non-polar infiltration and embedding materials such as epoxy or paraffin, in which polar dyes display little solubility, together with staining the tissue with polar dyes, allows the polar dyes to be partitioned into the tissue to stain hydrophilic components such as proteins and inhibits the dyes from entering the surrounding medium, promoting a high contrast image.
Alternatively, non-polar, fat-soluble (i.e., hydrophobic) dyes can be employed to stain lipid-rich structures in tissue, for example cell membranes. In such a situation, polar embedding materials such as glycol methacrylate (Polysciences, Inc. Warrington, PA) are employed to prevent diffusion of the non-polar dyes from the tissues into the embedding medium, thereby enhancing contrast in the tissue image.
A primary reason for the invention's importance is that the infiltration and embedding medium is not removed following en bloc staining and prior to imaging in some types of microscopy, including block face microscopy. Therefore it, is important for the creation of high contrast images using these techniques that image signals originating from the embedding material itself be eliminated; i.e., high contrast between the sample and the embedding medium is essential. Thus, because of the selection of relatively hydrophobic dyes for use with polar embedding media such as glycol methacrylate and Carbowax (solid polyethylene glycol; Union Carbide Corp., Danbury CT), dyes from the tissue sample, previously stained en bloc, are prevented from entering the surrounding medium. The maintenance of embedding medium free from dye leads to improved contrast between the stained tissue and the surrounding medium.
Other features and advantages of the invention will be apparent from the following detailed description, and from the claims.
DETAILED DESCRIPTION The solubility of any dye in a given medium can be experimentally determined for any given medium. For many dyes, solubility can be determined using references such as, for example, the Merck Index. Solubility can be expressed in terms of grams of solute/volume of solvent (g/lOOmL or g/L), as a percent (w/v; lOOg/lOOmL = 100%), or in terms of molarity or molality. For example, neutral red (3-amino-7-dimethylamino-2-methylphenazine hydrochloride), which stains the golgi apparatus, exhibits 4.0% (0.4g/L) solubility in water, 1.8% in absolute ethanol, 3.0% in ethylene glycol, and practically no solubility in xylene (Merck index, supra). Another dye, Eosin Y, has the following solubility: 44.0% in water; 2.0% in ethanol; 25.0%) in Cellosolve; 27.5% in ethylene glycol; and less than 0.1 % in xylene (Electron Microscopy Sciences, Fort Washington, PA, 1999 catalog). The most important element of the method of the invention is that the dye solubility in the embedding solution is less than the dye solubility in the staining solution. The lower the percentage of solubility in the embedding solution compared to that in the staining solution, the higher the contrast. Preferably, this percentage is less than 50%, more preferably less than 20%, and most preferably less than 10%, or even 2%.
Table 1 contains a list of dyes compatible with polar staining solutions, and corresponding non-polar embedding media suitable for the invention described herein. Table 1 also contains a list of polar embedding media compatible with Nile Red staining of lipids. These lists are for illustrative purposes, and are not limiting in any way. It is understood that other dyes, such as those listed in Conn, H.J. "Biological Stain" 9th ed., The Williams and Wilkens Co., Baltimore 1977, may be compatible with one or more embedding medium listed below. Similarly, other embedding media may be compatible with the dyes, provided, for example, in Table 1 or in Conn (supra).
ABLE 1
Figure imgf000008_0001
EXAMPLES Example 1 :
A tissue preparation where proteins in the sample are to be en bloc stained contains the following components, in which the dye is highly water soluble and the embedding medium is hydrophobic:
Dye: 2% aqueous solution of eosin Y fluorescent stain (Sigma Chemicals, St. Louis, MO). Embedding/infiltration medium: paraffin-based embedding medium
(Surgipath Medical Industries Inc., Richmond IL). Opacification agent: saturated Fat Brown RR (Solvent Brown 1 ; Sigma Chemicals, St. Louis, MO)
Opacified medium is prepared by dissolving an excess of opacification agent in molten paraffin under moderate stirring. The mixture is allowed to settle for one hour under continued heating, and then decanted. Tissue samples are stained by immersion in the eosin Y solution, and subsequently processed through graded alcohols and xylene, then infiltrated with and embedded in the opacified medium. Tissue blocks are imaged on block face microscope. Example 2:
A tissue preparation where nucleic acids in the sample are to be stained, in which the dye is highly water soluble and the embedding medium is hydrophobic, contains the following components: Dye: 1% aqueous solution of propidium iodide stain (Sigma Chemicals, St.
Louis, MO). Embedding/infiltration medium: Epon epoxy medium (Polysciences, Inc., Warrington, PA).
Epon is prepared according to manufacturer's instructions. Tissue samples are stained by immersion in the propidium iodide solution, and subsequently processed through graded alcohols and xylene, then infiltrated with and embedded in the epoxy medium. Tissue blocks are imaged on a surface imaging microscope.
Example 3:
A tissue preparation method where neutral lipids in the sample are to be stained, contains the following components, in which the dye has low water solubility and the embedding medium is highly water soluble:
Dye: 1% solution of Nile Red stain (Molecular Probes, Eugene, OR), dissolved in 2-methoxyethanol. Embedding/infiltration medium: Full strength glycol methacrylate catalyzed infiltration resin (JB-4, Polysciences, Inc., Warrington, PA) Tissue samples are placed in the stain solution in individual lOmL vials and mixed by rotation for 24 hours. The infiltrated and stained samples are then transferred to 2mL embedding capsules with an excess of formulation, mixed by rotation for 24 hours, centrifuged at 5,000 m for 10 minutes to facilitate settling of the sample, and allowed to polymerize at room temperature (approximately 1 hour). The block is imaged on a surface imaging microscope.
REFERENCES
Laboratory Methods in Histotechnology: Prepared by the Armed Forces Institute of Pathology, ed. Prophet, E.B., Mills B., Arrington J.B., Sobin L.H. American Registry of Pathology, Washington, D.C. 1992
Carson, F. L. Histotechnology: A Self-Instructional Text. ASCP Press,
American Society of Pathologists, Chicago 1990
Sheehan, D.C, Hrapchak, B.B. Theory and Practice of Histotechnology. 2nd ed. Battelle Press, Columbus OH 1980
U.S. patent # 4,960,330 "Image Recording Apparatus"
All patents and publications referenced herein are hereby incoφorated by reference.
What is claimed is:

Claims

aims 1. A method for en bloc staining and embedding a sample, said method comprising: a) immersing said sample in a staining solution containing a dye that binds reversibly to a component of said sample; and b) embedding said sample in an embedding medium, wherein said dye is no more than fifty percent as soluble in said embedding medium as it is in said staining solution.
2. The method of claim 1, wherein said embedding is also the infiltrating substance.
3. The method of claim 1, wherein said embedding medium includes an opacification agent.
4. The method of claim 1, wherein said dye is no more than twenty percent as soluble in said embedding medium as it is in said staining solution.
5. The method of claim 1, wherein said dye is no more than ten percent as soluble in said embedding medium as it is in said staining solution.
6. The method of claim 1, wherein said dye is no more than two percent as soluble in said embedding medium as it is in said staining solution.
7. The method of claim 1, wherein the sample comprises biological tissue.
PCT/US2000/001953 1999-02-19 2000-01-26 Combined en bloc staining and embedding process Ceased WO2000049383A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP00905746A EP1155300A4 (en) 1999-02-19 2000-01-26 Combined en bloc staining and embedding process
AU27381/00A AU2738100A (en) 1999-02-19 2000-01-26 Combined en bloc staining and embedding process
HK02106739.1A HK1045189A1 (en) 1999-02-19 2000-01-26 Combined en bloc staining and embedding process
JP2000600075A JP2002537554A (en) 1999-02-19 2000-01-26 Histological processing of tissues and other substances

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25360799A 1999-02-19 1999-02-19
US09/253,607 1999-02-19

Publications (1)

Publication Number Publication Date
WO2000049383A1 true WO2000049383A1 (en) 2000-08-24

Family

ID=22960971

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/001953 Ceased WO2000049383A1 (en) 1999-02-19 2000-01-26 Combined en bloc staining and embedding process

Country Status (7)

Country Link
EP (1) EP1155300A4 (en)
JP (1) JP2002537554A (en)
CN (1) CN1340156A (en)
AU (1) AU2738100A (en)
HK (1) HK1045189A1 (en)
TW (1) TWI252912B (en)
WO (1) WO2000049383A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003100384A1 (en) * 2002-05-28 2003-12-04 Diapath S.R.L. Composition for the preparation of histological, autopsical, cytological samples
ATE350657T1 (en) * 2003-06-30 2007-01-15 Groningen Acad Ziekenhuis METHOD FOR PREPARING HISTOLOGICAL SAMPLES
US9234823B2 (en) * 2005-09-06 2016-01-12 Leica Biosystems Melbourne Pty Ltd Method and apparatus for handling tissue samples
FR2891052B1 (en) * 2005-09-21 2007-12-21 Histolex Soc Responsabilite Li PROCESS FOR PREPARING A SAMPLE
CN105738182A (en) * 2016-02-25 2016-07-06 河南中医学院 Fluorescent staining method for observing plant microstructure
CN111610078B (en) * 2020-07-03 2021-12-14 中国科学技术大学 Biological tissue clearing reagent and biological tissue clearing method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960330A (en) * 1985-07-16 1990-10-02 Kerschmann Russell L Image recording apparatus
US5629080A (en) * 1992-01-13 1997-05-13 Hercules Incorporated Thermally bondable fiber for high strength non-woven fabrics
US5858990A (en) * 1997-03-04 1999-01-12 St. Elizabeth's Medical Center Fas ligand compositions for treatment of proliferative disorders

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960330A (en) * 1985-07-16 1990-10-02 Kerschmann Russell L Image recording apparatus
US5629080A (en) * 1992-01-13 1997-05-13 Hercules Incorporated Thermally bondable fiber for high strength non-woven fabrics
US5858990A (en) * 1997-03-04 1999-01-12 St. Elizabeth's Medical Center Fas ligand compositions for treatment of proliferative disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FASSEL ET AL.: "Comparison of Alcian Blue and Ruthenium red Effects on preservation of outer envelope ultrastructure in methanotropic bacteria", MICROSCOPY RESEARCH AND TECHNIQUE,, vol. 20, no. 1, January 1992 (1992-01-01), pages 87 - 94, XP002927937 *
See also references of EP1155300A4 *

Also Published As

Publication number Publication date
HK1045189A1 (en) 2002-11-15
JP2002537554A (en) 2002-11-05
AU2738100A (en) 2000-09-04
TWI252912B (en) 2006-04-11
EP1155300A1 (en) 2001-11-21
EP1155300A4 (en) 2003-05-28
CN1340156A (en) 2002-03-13

Similar Documents

Publication Publication Date Title
Culling et al. Cellular pathology technique
Müller‐Reichert et al. Cryoimmobilization and three‐dimensional visualization of C. elegans ultrastructure
US7618828B2 (en) Method for histoprocessing
CN1100256C (en) Fixing and supporting method for biological detection sample and its fixing and supporting agent and embedding box
Blackstad Electron microscopy of Golgi preparations for the study of neuronal relations
Wolfe Tissue processing
US20080090269A1 (en) Compositions and methods for preparing specimens for microscopic analysis
US6017725A (en) Cytological fixative and dehydrating agent for treating histological and cytological tissue
US6372512B1 (en) Combined en bloc staining and embedding process
KR100458860B1 (en) Auxiliary Tool for Examination of Biopsy Specimen
WO2000049383A1 (en) Combined en bloc staining and embedding process
WO2016013949A2 (en) Biomimetic gellable colloid for encoding, processing and sectioning histological samples
CN101351692B (en) Method for preparing a sample
An et al. Principles of embedding and common protocols
JP2602789B2 (en) A fat-soluble replacement agent for replacing a dehydrating agent for preparing a tissue sample and a method for preparing a tissue sample using the fat-soluble replacement agent
Vanický et al. Formaldehyde–hardened albumin as a non-penetrating embedding matrix for frozen and vibratome sectioning
Chaudhuri Basic Histological Techniques (MicroTechniques) for Staining of Animal Tissue
TW463042B (en) System for processing and imaging
Inman Nongraded dehydration and low-pressure infiltration for rapid celloidin embedding of brain tissue
Efimov POLYETHYLENE GLYCOL-CELLOIDIN MIXTURE FOR HISTOLOGICAL AND HISTOCHEMICAL
CN118050231A (en) Compositions and methods for three-dimensional tissue staining
CN119698237A (en) Cryotreatment of cryoprotected tissue
Samuel Dr. Gheena Research, 9,(02), 46795-46799
RU2241988C2 (en) Means for fixing biological material
Agarwal et al. To evaluate the efficacy of dishwashing soap (DWS) solution, coconut oil, cedarwood oil and limonene as a substitute to xylene in routine Hematoxylin and Eosin (H & E) staining procedure

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00803847.3

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2000 600075

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2000905746

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000905746

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWR Wipo information: refused in national office

Ref document number: 2000905746

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000905746

Country of ref document: EP